Abstract:Background and aims Endoscopic full-thickness resection (EFTR) has been increasingly applied in the treatment of gastric submucosal tumors (G-SMTs) with explorative intention. This study aimed to compare the efficacy, tolerability, and clinical outcomes of EFTR and surgical intervention for the management of muscularis propria (MP)-derived G-SMTs. Methods Between September 2011 and May 2019, the clinical records of patients with MP-derived G-SMTs undergoing EFTR at our endoscopic unit were collected. A cohort of people with primary MP-derived G-SMTs treated by surgery was matched in a 1:1 ratio to EFTR group with regard to patients’ baseline characteristics, clinicopathologic features of the tumor and the procedure date. The perioperative outcomes and follow-up data were analyzed. Results In total, 62 and 62 patients were enrolled into the surgery and EFTR group, respectively, with median follow-up of 786 days. The size of G-SMTs (with ulceration) ranged from 10 to 90 mm. For patients with tumor smaller than 30 mm, surgery and EFTR group presented comparable procedural success rate (both were 100%), en bloc resection rate (100% vs. 94.7%), tumor capsule rupture rate (0% vs. 5.3%), and pathological R0 resection rate (both were 100%). EFTR had a statistically significant advantage over surgery for estimated blood loss (3.12 ± 5.20 vs. 46.97 ± 60.73 ml, p ≤ 0.001), discrepancy between the pre- and postprocedural hemoglobin level (5.18 ± 5.43 vs. 9.84 ± 8.25 g/L, p = 0.005), bowel function restoration [1 (0–5) vs. 3 (1–5) days, p ≤ 0.001], and hospital cost (28,617.09 ± 6720.78 vs. 33,963.10 ± 13,454.52 Yuan, p = 0.033). The patients with tumor larger than 30 mm showed roughly the same outcomes after comparison analysis of the two groups. However, the clinical data revealed lower en bloc resection rate (75.0% vs. 100%, p = 0.022) and higher tumor capsule rupture rate (25.0% vs. 0%, p = 0.022) for EFTR when compared to surgery. The procedure time, duration of postprocedural fasting and antibiotics usage, and hospital stay of the two groups were equivalent. The occurrence rate of adverse events within postoperative day 7 were 74.2% and 72.6% after EFTR and surgery, respectively ( p = 1.000). No complications occurred during the follow-up. Conclusion For treatment of MP-derived G-SMTs (with or without ulceration), our study showed the feasibility and safety of EFTR, which also provided better results in terms of procedural blood loss, the postoperative bowel function restoration and cost-effectiveness when compared to surgery, whereas the surgery was superior in en bloc resection rate for G-SMTs larger than 30 mm. The postprocedural clinical outcomes seemed to be equivalent in these two resection methods.

Comparison of modified cap-assisted endoscopic mucosal resection and endoscopic submucosal dissection in treating intraluminal gastric gastrointestinal stromal tumor (≤20 mm)

Comparison of Endoscopic Submucosal Dissection and Surgery for the Treatment of Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single-Center Study (with Video)

Resection of the Gastric Submucosal Tumor (G-SMT) Originating from the Muscularis Propria Layer: Comparison of Efficacy, Patients' Tolerability, and Clinical Outcomes Between Endoscopic Full-Thickness Resection and Surgical Resection

Endoscopic Mucosal Resectionvsendoscopic Submucosal Dissection for Rectal Carcinoid Tumours: a Systematic Review and Meta-Analysis

Comparison of endoscopic resection and gastrectomy for the treatment of early gastric cancer: a meta-analysis

Comparing endoscopic mucosal resection with endoscopic submucosal dissection: the different endoscopic techniques for colorectal tumors

Comparison of Endoscopic Full-Thickness Resection and Cap-Assisted Endoscopic Full-Thickness Resection in the Treatment of Small (≤1.5 Cm) Gastric GI Stromal Tumors

Effects Analysis of Endoscopic Submucosal Tunnel Dissection in Treatment of Upper Gastrointestinal Tumor

Comparison of endoscopic therapies for rectal carcinoid tumors: Endoscopic mucosal resection with circumferential incision versus endoscopic submucosal dissection.

A New Endoscopic Technique for Specific Gastrointestinal Stromal Tumors: a Retrospective Cohort Study

Comparison of the efficacy and safety of endoscopic submucosal excavation and full-thickness resection for intraluminal gastric stromal tumors

Comparing endoscopic mucosal resection with endoscopic submucosal dissection in colorectal adenoma and tumors: Meta-analysis and system review

Comparison of Treatment Outcomes Between Laparoscopic and Endoscopic Surgeries for Relatively Small Gastric Gastrointestinal Stromal Tumors.

Endoscopic Resection Therapies for Rectal Neuroendocrine Tumors: A Systematic Review and Meta‐analysis

Efficacy and Safety of Four Different Endoscopic Treatments for Early Esophageal Cancer: a Network Meta-analysis

Comparison of Safety and Short‐term Outcomes Between Endoscopic and Laparoscopic Resections of Gastric Gastrointestinal Stromal Tumors with a Diameter of 2–5 Cm

Safety and efficacy of a modified endoscopic full-thickness resection technique for gastric submucosal tumors: a case series

Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Colorectal Laterally Spreading Tumors: a Meta-Analysis.

Endoscopic mucosal resection-precutting vs conventional endoscopic mucosal resection for sessile colorectal polyps sized 10-20 mm

Endoscopic mucosal resection in the treatment of the gastrointestinal superficial tumors

Comparison of Endoscopic Submucosal Dissection Application on Mucosal Tumor and Subepithelial Tumor in stomach